Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Krawczyk

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Scientific Reports|August 3, 2017
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patientsChristoph Jüngst, Vanessa Stadlbauer, Matthias C Reichert, et al.
European Journal of Clinical Investigation|May 29, 2021
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationshipAgnieszka Karkucinska-Wieckowska, Ines C M Simoes, Piotr Kalinowski, et al.
Scientific Reports|December 24, 2021
MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitisMaciej K Janik, Wiktor Smyk, Beata Kruk, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 30, 2024
Evaluation of Google Search Trends for Liver Diseases in EuropeAndreas Teufel, Timo Itzel, Anca Zimmermann, et al.
Nutrients|November 28, 2019
Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver DiseaseInes C M Simoes, Justyna Janikiewicz, Judith Bauer, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
Christian A Hudert, Martin Jankofsky, Verena Keitel-Anselmino, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
European Journal of Heart Failure|June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trialMichael Böhm, Javed Butler, Marcin Krawczyk, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2019
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitisMalte Rühlemann, Timur Liwinski, Femke-Anouska Heinsen, et al.
Nature Communications|February 5, 2026
MiRNAs shape mouse age-independent tissue adaptation to spaceflight via ECM and developmental pathwaysFriederike Grandke, Shusruto Rishik, Viktoria Wagner, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Scientific Reports|August 3, 2017
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patientsChristoph Jüngst, Vanessa Stadlbauer, Matthias C Reichert, et al.
European Journal of Clinical Investigation|May 29, 2021
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationshipAgnieszka Karkucinska-Wieckowska, Ines C M Simoes, Piotr Kalinowski, et al.
Scientific Reports|December 24, 2021
MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitisMaciej K Janik, Wiktor Smyk, Beata Kruk, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 30, 2024
Evaluation of Google Search Trends for Liver Diseases in EuropeAndreas Teufel, Timo Itzel, Anca Zimmermann, et al.
Nutrients|November 28, 2019
Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver DiseaseInes C M Simoes, Justyna Janikiewicz, Judith Bauer, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
Christian A Hudert, Martin Jankofsky, Verena Keitel-Anselmino, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
European Journal of Heart Failure|June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trialMichael Böhm, Javed Butler, Marcin Krawczyk, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2019
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitisMalte Rühlemann, Timur Liwinski, Femke-Anouska Heinsen, et al.
Nature Communications|February 5, 2026
MiRNAs shape mouse age-independent tissue adaptation to spaceflight via ECM and developmental pathwaysFriederike Grandke, Shusruto Rishik, Viktoria Wagner, et al.
Pageof 22